{"entity":{"type":"insider","cik":"0001966836","url":"/insider/0001966836","json_url":"/insider/0001966836.json","name":"OrbiMed Asia GP IV, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":3,"first":"2023-05-02","last":"2024-01-31","span_basis":"filed_date"},"name_variants":[{"name":"OrbiMed Asia GP IV, L.P.","source":"filing","n_filings":3,"first_seen":"2023-05-02","last_seen":"2024-01-31"}],"transactions":[{"id":2128766,"accession":"0001104659-24-008799","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-24-008799","line_url":"/filing/0001104659-24-008799","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"ArriVent Biopharma, Inc.","issuer_ticker":"AVBP","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Advisors IV Ltd; OrbiMed Asia GP IV, L.P.; OrbiMed Capital GP VIII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Advisors IV Ltd","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":444444.0,"shares_display":"444,444","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":7999992.0,"total_display":"7,999,992.00","total_whole":"7,999,992","shares_owned_after":1513664.0,"shares_owned_after_display":"1,513,664","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-30","filed_date":"2024-01-31","scope":"insider","n_lines":2},{"id":8464461,"accession":"0000947871-23-000541","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000947871-23-000541","line_url":"/filing/0000947871-23-000541","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Kinnate Biopharma Inc.","issuer_ticker":"KNTE","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Asia GP IV, L.P.; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC; OrbiMed Advisors IV Ltd; ORBIMED CAPITAL LLC; OrbiMed Capital GP VII LLC; OrbiMed Capital GP VIII LLC","owner_display_name":"OrbiMed Asia GP IV, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":981023.0,"shares_display":"981,023","price_per_share":2.82,"price_display":"2.82","price_state":"stated","total_value":2766484.86,"total_display":"2,766,484.86","total_whole":"2,766,485","shares_owned_after":1368339.0,"shares_owned_after_display":"1,368,339","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-05","filed_date":"2023-05-08","scope":"insider","n_lines":2},{"id":8464453,"accession":"0000947871-23-000541","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-23-000541","line_url":"/filing/0000947871-23-000541","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Kinnate Biopharma Inc.","issuer_ticker":"KNTE","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Asia GP IV, L.P.; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC; OrbiMed Advisors IV Ltd; ORBIMED CAPITAL LLC; OrbiMed Capital GP VII LLC; OrbiMed Capital GP VIII LLC","owner_display_name":"OrbiMed Asia GP IV, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":479909.0,"shares_display":"479,909","price_per_share":2.75,"price_display":"2.75","price_state":"stated","total_value":1319749.75,"total_display":"1,319,749.75","total_whole":"1,319,750","shares_owned_after":4738453.0,"shares_owned_after_display":"4,738,453","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-04","filed_date":"2023-05-08","scope":"insider","n_lines":3},{"id":7857073,"accession":"0000947871-23-000515","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000947871-23-000515","line_url":"/filing/0000947871-23-000515","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Kinnate Biopharma Inc.","issuer_ticker":"KNTE","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Advisors IV Ltd; OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC; OrbiMed Asia GP IV, L.P.; OrbiMed Capital GP VIII LLC; ORBIMED CAPITAL LLC","owner_display_name":"OrbiMed Genesis GP LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":338262.0,"shares_display":"338,262","price_per_share":2.67,"price_display":"2.67","price_state":"stated","total_value":903159.54,"total_display":"903,159.54","total_whole":"903,160","shares_owned_after":4425462.0,"shares_owned_after_display":"4,425,462","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-02","filed_date":"2023-05-02","scope":"insider","n_lines":3},{"id":7857058,"accession":"0000947871-23-000515","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000947871-23-000515","line_url":"/filing/0000947871-23-000515","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Kinnate Biopharma Inc.","issuer_ticker":"KNTE","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Advisors IV Ltd; OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC; OrbiMed Asia GP IV, L.P.; OrbiMed Capital GP VIII LLC; ORBIMED CAPITAL LLC","owner_display_name":"OrbiMed Genesis GP LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":716157.0,"shares_display":"716,157","price_per_share":2.62,"price_display":"2.62","price_state":"stated","total_value":1876331.34,"total_display":"1,876,331.34","total_whole":"1,876,331","shares_owned_after":4204852.0,"shares_owned_after_display":"4,204,852","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-01","filed_date":"2023-05-02","scope":"insider","n_lines":3},{"id":7857037,"accession":"0000947871-23-000515","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-23-000515","line_url":"/filing/0000947871-23-000515","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Kinnate Biopharma Inc.","issuer_ticker":"KNTE","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Advisors IV Ltd; OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC; OrbiMed Asia GP IV, L.P.; OrbiMed Capital GP VIII LLC; ORBIMED CAPITAL LLC","owner_display_name":"OrbiMed Genesis GP LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350749.0,"shares_display":"350,749","price_per_share":2.55,"price_display":"2.55","price_state":"stated","total_value":894409.95,"total_display":"894,409.95","total_whole":"894,410","shares_owned_after":3737784.0,"shares_owned_after_display":"3,737,784","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-28","filed_date":"2023-05-02","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001868279","name":"ArriVent Biopharma, Inc.","url":"/issuer/0001868279","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2024-01-31","last_seen":"2024-01-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001797768","name":"Kinnate Biopharma Inc.","url":"/issuer/0001797768","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2023-05-02","last_seen":"2023-05-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001966836","retrieved_at":"2026-08-24T13:08:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}